Dermata reports 77% of participants see skin improvement in four-week Tome study
DRMA•Dermata Therapeutics said 77% of participants in its four-week Tome study saw skin improvement. The open-label study enrolled 31 participants, and the company said the treatment has received more than 1,000 orders since launch.
1. Study results
Dermata Therapeutics released additional results from its completed open-label cosmetic study of Tome Foundational Treatment. The study enrolled 31 participants who used the treatment once weekly for four weeks; 77% saw skin improvement.
2. Treatment and orders
Participants reported improved skin appearance with less downtime over successive treatments, and no treatment-related adverse events were reported. The recently launched skincare treatment has received more than 1,000 orders.



